News

The results of the annual award in the HR field of the Russian pharmaceutical industry "The Employer of the Future - 2025" were summed up and the winners were announced at the festive ceremony on March 25. The voting for the best employer has been held since October 2024 till March 2025 among the employees of different pharmaceutical companies in Russia. All participating companies were splitted into three categories depending on their headcount number:

- up to 100 employees
- from 100 to 1000 employees
- more than 1000 employees

Aristo Pharma was recognized as the best company in the 1st category and awarded in two nominations:
1. the Best Internal Atmosphere in the company
2. the General Director of the Year - Jonas Tryggvason got the highest number of votes

Among other nominees there were such large Russian and international pharmaceutical companies as AstraZeneca, Johnson & Johnson, Dr. Reddy's, Bayer, Binnopharm, Amgen, Lundbeck, Pharmstandard, Ozon Pharmaceuticals, Akrikhin, Biocard and many others. "The Employer of the Future" award is organized by the professional community Pharma & Medical Recruitment and held since October 2022.

"Good internal atmosphere is one of key advantages of every employer in the eyes of employees and potential candidates. Based on honesty and openness, inspiration and support, the internal atmosphere is the most important driver in achieving the strategic goals and strengthening the corporate culture, contributing into the establishment of trusting relationships, increasing the motivation and confidence of employees, maintaining team spirit and building a strong and productive team!" - says Jonas Tryggvason, General Director of Aristo Pharma (Russia & CIS).

The team of Aristo Pharma is very proud and happy for such great results!

The company highly appreciates the contribution of all employees for not having stayed aside and voted for the company! The participation in such big events gives us the opportunity to declare itself, to increase Aristo Pharma's brand awareness in the Russian pharmaceutical market and to take one more step towards the great success!